Bradley Merrill Thompson Quoted in “September Eyes Turn to CHIP Funding”POLITICO Morning eHealth September 5, 2017
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in POLITICO Morning eHealth, in “September Eyes Turn to CHIP Funding,” by Darius Tahir and Arthur Allen.
Following is an excerpt:
What You Missed in August:
Software guidelines finalized: The CDS Coalition issued final, voluntary, industry-written guidance for the design of medium risk clinical decision support software. The group of medical software companies “wants to give FDA confidence that for that software the [FDA] does not regulate [under the 21st Century Cures Act], industry will do an adequate job of self-regulation,” Bradley Merrill Thompson wrote on LinkedIn.